Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James J. Hagan is active.

Publication


Featured researches published by James J. Hagan.


Investigative Radiology | 1988

Comparative chemical structure and pharmacokinetics of MRI contrast agents.

Michael F. Tweedle; Stephen Eaton; William C. Eckelman; G. T. Gaughan; James J. Hagan; Paul W. Wedeking; Fred Yost

Tweedle MF, Eaton SM, Eckelman WC, Gaughan GT, Hagan JJ, Wedeking PW, Yost FJ. Comparative chemical structure and pharmacokinetics of MRI contrast agents. Invest Radiol 1988; 23(Suppl 1):S236‐S239. The blood clearance kinetics of five gadolinium complexes, Gd(L), were determined in rats and the results interpreted in terms of an open two‐compartment pharmacokinetic model. The complexes were tested in vitro for stability in serum and in aqueous solutions of ions that they might encounter in vivo and that might be expected to react with the Gd(L) complexes to produce uncomplexed gadolinium. Reaction with serum was observed in two instances. Chemical structural differences among the chelating ligands appear to govern the overall reactivity of their Gd(L) complexes. It may be inferred from the results that a preferred structural feature of the ligand is the presence of a 12‐membered 1,4,7,10‐tetraaza macrocycle.


Investigative Radiology | 1988

A predictive test for adverse reactions to contrast media. Preliminary results.

Stephen Eaton; James J. Hagan; Horng M. Tsay; Michael F. Tweedle; Eileen L. Nickoloff; Michael D. Loberg; Fred Yost

Eaton SM, Hagan JJ, Tsay HM, Tweedle MF, Nickoloff EL, Loberg MD, Yost FJ. A predictive test for adverse reactions to contrast media: preliminary results. Invest Radiol 1988;23(Suppl 1):S206‐S208. In a prospective study, whole blood samples drawn from patients prior to their being injected with contrast media were incubated with zymosan to activate the complement cascade. The samples were tested for various analytes, including C3a, thromboxane B2 (TxB2), beta thromboglobulin and platelet factor 4 (PF4). Of 207 patients receiving contrast media, only eight experienced reactions, which were mild. Levels of the platelet constituents were generally elevated in these patients. Specificity and sensitivity were 89% and 83%, respectively, for the combined TxB2 and PF4 radioimmunoassay data. Using the Wilcoxon‐Mann‐Whitney rank sum test, both PF4 and TxB2 were collected with RCM reactions at the R < .05 level. Although preliminary, the results suggest that RCM reactions are predictable by the in vitro test procedures described.


Archive | 1988

Substituted 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclo-dodecane and analogs

Michael F. Tweedle; Glen T. Gaughan; James J. Hagan


Archive | 1995

Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs

Michael F. Tweedle; Glen T. Gaughan; James J. Hagan


Archive | 1995

Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs

Michael F. Tweedle; Glen T. Gaughan; James J. Hagan


Analytical Chemistry | 1988

Fluorescence detection of gadolinium chelates separated by reversed-phase high-performance liquid chromatography

James J. Hagan; Susan Cicero. Taylor; Michael F. Tweedle


Archive | 1988

1-(substituant)-1,4,7-tris(carboxymethyl)-1,4,7,10- tetraazacyclododecane et composes analogues

Michael F. Tweedle; Glen T. Gaughan; James J. Hagan


Archive | 1988

Substituiertes 1,4,7-Triscarboxymethyl-1,4,7,10-tetraazacyclododecan und Analoga

Michael F. Tweedle; Glen T. Gaughan; James J. Hagan


Archive | 1988

Predictive test for adverse reactions to iodinated radiographic contrast media

Stephen Eaton; Horng-Mou Tsay; James J. Hagan; Frederick J. Yost


Archive | 1988

Substituiertes 1,4,7-Triscarboxymethyl-1,4,7,10-tetraazacyclododecan und Analoga Substituted 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs

Michael F. Tweedle; Glen T. Gaughan; James J. Hagan

Collaboration


Dive into the James J. Hagan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

William C. Eckelman

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge